LawPlayer
My bookmarks
Source

Commission Regulation (EU) 2020/2160 of 18 December 2020 amending Annex XIV to Regulation (EU) No 1907/2006 of the European Parliament and of the Council as regards the substance group 4-(1,1,3,3-Tetramethylbutyl)phenol, ethoxylated (covering well-defined substances and substances of unknown or variable composition, complex reaction products or biological materials, polymers and homologues) (Text with EEA relevance)

Commission Regulation (EU) 2020/2160 of 18 December 2020 amending Annex XIV to Regulation (EU) No 1907/2006 of the European Parliament and of the Council as regards the substance group 4-(1,1,3,3-Tetramethylbutyl)phenol, ethoxylated (covering well-defined substances and substances of unknown or variable composition, complex reaction products or biological materials, polymers and homologues) (Text with EEA relevance)

Regulation (EU) 2020/2160 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Annex XIV to Regulation (EC) No 1907/2006 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union . It shall apply from 4 July 2019.

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX In the table in Annex XIV to Regulation (EC) No 1907/2006, entry 42 concerning 4-(1,1,3,3 Tetramethylbutyl)phenol, ethoxylated (covering well-defined substances and UVCB substances, polymers and homologues) is amended as follows: (1) the text of column 4 ‘Latest application date’ is replaced by the following text: ‘(a) 4 July 2019 (*); (b) by way of derogation from point (a), 22 June 2022 for uses as follows: — for the research, development and production of medicinal products falling within the scope of Directive 2001/83/EC or medical devices or accessories to medical devices falling within the scope of Directive 93/42/EEC, Regulation (EU) 2017/745, Directive 98/79/EC or Regulation (EU) 2017/746 of the European Parliament and of the Council  ( (**) ) , in view of their use for the diagnosis, treatment or prevention of the coronavirus disease (COVID-19), — in medical devices or accessories to medical devices falling within the scope of Directive 93/42/EEC, Regulation (EU) 2017/745, Directive 98/79/EC or Regulation (EU) 2017/746, for the diagnosis, treatment or prevention of COVID-19. ( (**) )   Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU ( OJ L 117, 5.5.2017, p. 176 ).’;" (2) the text of column 5 ‘Sunset date’ is replaced by the following text: ‘(a) 4 January 2021 (**); (b) by way of derogation from point (a), 22 December 2023 for uses as follows: — for the research, development and production of medicinal products falling within the scope of Directive 2001/83/EC or medical devices or accessories to medical devices falling within the scope of Directive 93/42/EEC, Regulation (EU) 2017/745, Directive 98/79/EC or Regulation (EU) 2017/746, in view of their use for the diagnosis, treatment or prevention of COVID-19, — in medical devices or accessories to medical devices falling within the scope of Directive 93/42/EEC, Regulation (EU) 2017/745, Directive 98/79/EC or Regulation (EU) 2017/746, for the diagnosis, treatment or prevention of COVID-19.’ ( (**) )   Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU ( OJ L 117, 5.5.2017, p. 176 ).’;’

Other acts of the same type
Commission Implementing Regulation (EU) 2023/255 of 6 February 2023 concerning the renewal of the authorisation of naringin as a feed additive for all animal species and repealing Implementing Regulation (EU) No 870/2012 (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/256 of 6 February 2023 concerning the authorisation of a preparation of Limosilactobacillus reuteri DSM 32203 as a feed additive for dogs and a preparation of Limosilactobacillus reuteri DSM 32264 as a feed additive for cats (holder of authorisation: NBF Lanes s.r.l.) (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/257 of 6 February 2023 correcting Implementing Regulation (EU) 2022/1412 concerning the authorisation of ylang ylang essential oil from Cananga odorata (Lam) Hook f. & Thomson as a feed additive for all animal species (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/316 of 6 February 2023 entering a name in the register of protected designations of origin and protected geographical indications (‘Goranski medun’ (PDO))Commission Implementing Regulation (EU) 2023/317 of 6 February 2023 approving non-minor amendments to the specification for a name entered in the register of protected designations of origin and protected geographical indications (‘Colline di Romagna’ (PDO))Commission Implementing Regulation (EU) 2023/318 of 6 February 2023 approving Union amendment to the specification for a Protected Designation of Origin or a Protected Geographical Indication (‘Almansa’ (PDO))Council Regulation (EU) 2023/250 of 4 February 2023 amending Regulation (EU) No 833/2014 concerning restrictive measures in view of Russia’s actions destabilising the situation in UkraineCommission Implementing Regulation (EU) 2023/251 of 4 February 2023 amending Council Regulation (EU) No 833/2014 concerning restrictive measures in view of Russia’s actions destabilising the situation in UkraineCommission Implementing Regulation (EU) 2023/249 of 3 February 2023 amending for the 333rd time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da’esh) and Al-Qaida organisationsCommission Regulation (EU) 2023/334 of 2 February 2023 amending Annexes II and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for clothianidin and thiamethoxam in or on certain products (Text with EEA relevance)Commission Delegated Regulation (EU) 2023/744 of 2 February 2023 correcting Delegated Regulation (EU) 2022/1172 as regards transitional provisions to facilitate conditionality and cross-compliance checks for certain area-based payments under the common agricultural policyCommission Implementing Regulation (EU) 2023/215 of 1 February 2023 correcting the Spanish language version of Implementing Regulation (EU) 2021/1100 imposing a definitive anti-dumping duty and definitively collecting the provisional duty imposed on imports of certain hot-rolled flat products of iron, non-alloy or other alloy steel originating in Turkey

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next